Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
December 2017

Generic vs Brand-Name Antipsychotics
For some antipsychotics, generic formulations may be less bioavailable and less efficacious than the brand-name product.

Can Lithium Decrease the Risk of Dementia?
In a study in Denmark, lithium exposure in drinking water was significantly lower in people with dementia than in controls.

Ketamine for Social Anxiety Disorder?
Preliminary data suggest that ketamine (Ketalar and others) may relieve anxiety.

Postpartum Depression: Experimental Treatment with a GABA Modulator
In a study of women with severe postpartum depression, brexanolone, a formulation of allopregnanolone, was associated with decreased depressive symptoms.

In Brief
Researchers Find Evidence of a Lymphatic System in the Brain

CME 2017
If you are interested in completing the Continuing Medical Education (CME) posttest and evaluation for 2017, please go to btpnews.com/cme.

2013-2017 Bound Volume
A 5-year bound volume with a cumulative index covering the years 2013 to 2017 is available for purchase. This volume is available on thumb drive only; no print version will be published.

Antipsychotics for First-Episode Schizophrenia
For patients with first-episode schizophrenia, second-generation antipsychotics have a broad array of side effects but differ little in efficacy.

Sweet Sorrow
This month's issue of the newsletter concludes our 40th year and marks the end of a journey.

Subscription Refunds
If you paid for a subscription past December 2017, you will receive a pro-rated refund check by the end of December. Starting December 15, 2017, a free downloadable zip file will be available at btpnews.com for all archives from 2000 to 2017.

About Alan J. Gelenberg, M.D.

Alan J. Gelenberg, M.D. is a Professor Emeritus at the University of Arizona and has chaired Departments of Psychiatry at Arizona and Penn State. He has also been on the faculty of Harvard Medical School, MIT, and the University of Wisconsin. He is Editor-in-Chief of the Journal of Clinical Psychiatry, the field's most widely read peer-reviewed journal, and founding author of Biological Therapies in Psychiatry Newsletter.

Dr. Gelenberg has been lead author of manuscripts in the Lancet, New England Journal of Medicine, and Journal of the AMA and has published over 280 scientific articles, editorials, and book chapters. He chaired the American Psychiatric Association's (APA) workgroup on Treatment Guidelines for Major Depressive Disorder, 3rd edition, was on a joint APA/AMA taskforce on similar guidelines for primary care and a committee to advise the U.S. Centers for Disease Control about depression. He helped create the ASEX scale to monitor sexual side effects of antidepressants and electronic versions of suicide-assessment instruments.

Often a guest lecturer and visiting professor throughout the world, Dr. Gelenberg has sat on National Institute of Mental Health committees, is a Distinguished Life Fellow of the APA, former chair of its Committee on Research on Psychiatric Treatments, past President of the West Coast College of Biological Psychiatry, fellow of the American College of Neuropsychopharmacology, and member of the American College of Psychiatrists. He is on the Council of the Central Pennsylvania Psychiatric Society, Boards of Directors of the American Society of Clinical Psychopharmacology and the Pennsylvania Psychiatric Institute, Professional Advisory Council of the Neuroleptic Malignant Syndrome Information Service, Scientific Advisory Board of the Depression and Bipolar Support Alliance, and NCDEU Steering Committee. He chairs the Data and Safety Monitoring Board of the NIMH study Treating Depression and Insomnia (TRIAD). Consistently listed in The Best Doctors in America and America's Top Doctors, he received an Exemplary Psychiatrist Award of the National Alliance for the Mentally Ill and two teaching awards at the University of Arizona. He has mentored numerous researchers, many of whom are now highly productive scientists.

A native of Philadelphia, Alan Gelenberg received an A.B. from Columbia University and M.D. from the University of Pennsylvania. After a year's internship in internal medicine at Presbyterian-University of Pennsylvania Medical Center, he was a resident in psychiatry at the Massachusetts General Hospital. For six years he was a commissioned officer in the U.S. Army Reserves. Dr. Gelenberg's wife was the first woman TV news anchor in Arizona, on the air for 34 years, and a candidate for the U.S. Congress. Between them, the Gelenbergs have five children.

If you have a question for Dr. Gelenberg, you can send him an email at drgelenberg@btpnews.com.